Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events
about
HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesHow HIV takes advantage of the cytoskeleton in entry and replicationThe broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelopeWhere in the Cell Are You? Probing HIV-1 Host Interactions through Advanced Imaging TechniquesEstimating the threshold surface density of Gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusionTRIM5 alpha cytoplasmic bodies are highly dynamic structures.Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosisAsn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.Single-molecule analysis of human immunodeficiency virus type 1 gp120-receptor interactions in living cells.A perspective of the dynamic structure of the nucleus explored at the single-molecule levelAn altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.CCR5 conformations are dynamic and modulated by localization, trafficking and G protein associationAlternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusionRestricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusionRole of gp120 trimerization on HIV binding elucidated with Brownian adhesive dynamicsSingle-cell imaging of HIV-1 provirus (SCIP).HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.Cholesterol Supplementation During Production Increases the Infectivity of Retroviral and Lentiviral Vectors Pseudotyped with the Vesicular Stomatitis Virus Glycoprotein (VSV-G)Live cell imaging of the HIV-1 life cycleEpidermal growth factor receptor-PI3K signaling controls cofilin activity to facilitate herpes simplex virus 1 entry into neuronal cells.Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.Evaluation of the cytopathicity (fusion/hemifusion) of patient-derived HIV-1 envelope glycoproteins comparing two effector cell lines.Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells. A fluorescence recovery after photobleaching at variable radii approach.HIV gp120-induced Interaction between CD4 and CCR5 Requires Cholesterol-rich Microenvironments Revealed by Live Cell Fluorescence Resonance Energy Transfer Imaging
P2860
Q26825087-2E8B6127-0521-44D8-B05B-0973CADB8D58Q27021639-FA66C30A-96F3-4813-9618-C9A609DEBFD4Q27472782-7109722D-DC91-49C3-B549-E54E8F06F4A3Q28077744-6BAACB11-AE42-4A0B-82B2-014C1D871E89Q28478341-D83C168A-A3A9-41A7-B9F2-B059F2AE7D41Q30479495-3F62763E-FBD0-4C40-B44C-9ED510648E33Q33725587-406222F1-8C7D-4F05-B3A4-7E385B1959F8Q33736823-E8B794D8-10C0-4D5D-9B7B-4DD83872F9B7Q34008699-09E51B4F-7D1F-42D9-AFB6-BCC9E18B0BF9Q34142829-EFCDFB5B-D472-4A6E-8A35-75C8B0ACABF2Q34579724-F9133F6D-138C-47C7-987E-AF2D40C98811Q34987062-4D805DB7-6AB8-4331-8DAE-547FEB1D6095Q35062297-D529E51D-3055-4980-9563-0D6144A78521Q35106596-D49704D0-DA21-4059-B90E-2ADB480C27F6Q35274763-0A82C11F-68E6-4A67-A869-C22A1BD8DCA2Q35585420-DE957FB6-7CE5-44F6-8D4A-6ECA1F896BF4Q35857576-D0B862C4-6920-4C6C-AF00-1601144C0DF0Q36303032-9C0D062E-96FF-42DA-86B7-5E8C6C0FB66CQ36717705-E465D2F3-76D5-4DD9-9186-29F47BFEB0E4Q36747516-8A7FEE32-6DCE-434E-B898-5C92391D1E5CQ36798434-5F9A15B9-25DD-4495-9B1C-E5E1E3BC8798Q37146636-11653D0E-BF81-4178-9CFA-C2B47F8556EBQ37314575-5CEB27D9-8E0E-4457-9330-8498C98C2D01Q37519854-67B03E8D-6F38-40A2-9698-28B80E85B1D8Q37834097-49DB7490-6AA2-49E3-B077-25BE11E8B48FQ39377648-E41F76CF-CFF1-4D7E-9464-F9816C790852Q39523186-025E33D3-8E8D-44BF-A033-0F2AFD0E0D89Q40081130-07916516-AAF8-4AE5-8F1F-D70D02F48788Q57372582-67D30273-AC36-45E8-A2DD-4BEEFC4BA0FE
P2860
Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Mobility of the human immunode ...... or HIV fusion and entry events
@en
Mobility of the human immunodeficiency virus
@nl
type
label
Mobility of the human immunode ...... or HIV fusion and entry events
@en
Mobility of the human immunodeficiency virus
@nl
prefLabel
Mobility of the human immunode ...... or HIV fusion and entry events
@en
Mobility of the human immunodeficiency virus
@nl
P2860
P1433
P1476
Mobility of the human immunode ...... or HIV fusion and entry events
@en
P2093
Carolyn M Steffens
Thomas J Hope
P2860
P304
P356
10.1128/JVI.78.17.9573-9578.2004
P407
P577
2004-09-01T00:00:00Z